Glostrup, Denmark

Anders Krarup


Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 22(Granted Patents)


Location History:

  • Leiden, NL (2019 - 2021)
  • Glostrup, DK (2019 - 2024)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Anders Krarup**

Introduction

Anders Krarup is a distinguished inventor based in Glostrup, Denmark. With a remarkable portfolio consisting of seven patents, he has made significant strides in the field of vaccine development and infectious disease prevention. His work is primarily focused on innovative solutions for combating viral infections, particularly respiratory syncytial virus (RSV) and human immunodeficiency virus (HIV).

Latest Patents

Among his latest patents, Krarup has developed stabilized soluble pre-fusion RSV F proteins. These proteins are crucial in creating effective vaccines and treatments for RSV infections. His research on stable pre-fusion RSV F proteins highlights not only their compositions but also their applications in preventing and treating RSV infections.

Another notable patent involves mutant envelope proteins for HIV-1. Krarup has described compositions and vaccine combinations that utilize synthetic HIV envelope proteins. Through these inventions, he outlines methods aimed at inducing immune responses against HIV infection. Furthermore, he explores the use of viral expression vectors to enhance protective immunity against the virus.

Career Highlights

Anders Krarup is currently affiliated with Janssen Vaccines & Prevention B.V., where he continues to contribute to the development of vaccines that protect against viral infections. His expertise and dedication to the field of immunology are evident in his innovative approaches to vaccine formulation and disease prevention.

Collaborations

Throughout his career, Krarup has collaborated with esteemed professionals such as Johannes Petrus Maria Langedijk and Danielle Van Manen. These partnerships have facilitated the sharing of knowledge and resources, leading to enhanced research and development efforts in vaccinology.

Conclusion

The contributions of Anders Krarup to the fields of virology and immunology are both impactful and inspiring. His patents reflect a deep commitment to addressing global health challenges through innovative research and collaboration. As he continues his work at Janssen Vaccines & Prevention B.V., the scientific community eagerly anticipates further advancements stemming from his expertise and creativity.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…